[DOI] [PMC free article] [PubMed] [Google Scholar] 7.Deanfield J., Verma S., Scirica B.M., Kahn S.E., Emerson S.S., Ryan D., et al
Adems, el GIP puede influir en la distribucin de la grasa corporal y en la sensibilidad a la insulina, contribuyendo de forma indirecta a la regulacin del peso
For most patients, tirzepatide is the right choice now, with retatrutide as a potential option in 2028 for those who need more or achieved inadequate results
For adults with type 2 diabetes and obesity, Ozempics ability to address both conditions simultaneously makes it a compelling choice, though the weight loss drug benefits come with more gastrointestinal side effects during the initial weeks
This dual mechanismsurgical restriction plus hormonal appetite suppressionaddresses weight loss from two independent angles, potentially achieving outcomes that surgery alone cannot reach
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus